Since the post-acute phase, patients have occupational needs related to social reintegration, that improve the autonomy, social roles in family, at work and in the community.
Unmet needs could lead to a lower level of social reintegration. Healthcare professionals should be able to recognize the level of social reintegration of complex patients discharged from the Physical Medicine Rehabilitation (PRM) unit with the aim to identify those who need intervention aimed at improving social reintegration.
The preliminary Italian version of the RNL index (RNLI) will describe the social reintegration level of the target population, once its psychometric properties will be tested.
Full Title of Study: “Testing the Psychometric Properties of the Italian Version of the Reintegration to Normal Living Index in Complex Patients Discharge From Physical Medicine and Rehabilitation Unit: a Validation Study”
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: September 2020
The investigators will recruit three groups of participants to test the psychometric properties of the Italian version of the RNLI: complex patients, caregivers and stakeholders.
Phase_1: to test the Content validity. The content validity will be tested on 10 complex patients and 10 stakeholders, who will assess the clarity and relevance of the RNLI items, respectively. In this phase, complex patients are hospitalized in the PMR unit.
From this first phase, the investigators will obtain the preliminary Italian version of the RNLI to test its psychometric properties.
Phase_2: to test the Reliability, Construct validity and Responsiveness. During the hospitalization in the PMR unit, 138 patients and their caregivers will be recruited. During this phase, the investigators will detect the important occupational activities of complex patients enrolled through a semi-structured interview conducted in person.
After discharge, the investigators will contact the patients and their caregivers by telephone at different times (T0, T1 and T2) to test the following psychometric properties through the administration of the Italian version of the RNLI and the Canadian Occupational Performance Measure (COPM). Caregiver will have to answer to the RNLI as a proxy for the patient.
The contact times and the psychometric properties that will be tested are:
T0_ 2 weeks after discharge
- internal consistency
- inter-observer reliability
- convergent construct validity
T1_ 10-14 days after T0
- test-retest reliability
T2_ 6-8 weeks after T0
- discriminant construct validity
Clinical Trial Outcome Measures
- Phase_1: to test the Content validity of the Reintegration to Normal Living Index
- Time Frame: 3 months
- A group of complex patients and stakeholders will report the clarity and the relevance of the items of the Reintegration to Normal Living Index (RNLI), respectively. Thus, the content validity of the RNLI will be tested.
- Phase_2: to test the Reliability, Construct validity and Responsivness of the Reintegration to Normal Living Index
- Time Frame: 19 months
- The Reintegration to Normal Living Index (RNLI) and the Canadian Occupational Performance Measure (COPM) will be administer to the complex patients and their caregiver in different times to test the psychometric properties of the RNLI.
Participating in This Clinical Trial
- hospitalized in the PMR unit of AUSL-IRCCS of Reggio Emilia
- Rehabilitation Complexity Scale Extended ≥ 9
- Discharge at home
- language barrier
- comorbidities that limit communication and/or collaboration (eg aphasia, dementia, cognitive deficits, severe anxious-depressive syndromes pre-existent to hospitalization, etc.)
- discharge in residential structures, retirement homes or long-term care or transferred to acute wards for complications.
main caregivers of the patients enrolled
a rehabilitation healthcare professional with at least 3 years of clinical experience in rehabilitation and reintegration into the living environment of highly complex patients
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- Azienda Unità Sanitaria Locale Reggio Emilia
- Provider of Information About this Clinical Study
- Principal Investigator: Martina Pellegrini, Principal Investigator – Azienda Unità Sanitaria Locale Reggio Emilia
- Overall Official(s)
- Martina Pellegrini, Principal Investigator, AUSL of Reggio Emilia
- Overall Contact(s)
- Martina Pellegrini, +39 0522295189, firstname.lastname@example.org
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.